CN Patent

CN106939012B — 一种奈他地尔中间体的制备方法

Assigned to Anhui ailide Pharmaceutical Co.,Ltd. · Expires 2019-11-08 · 7y expired

What this patent protects

本发明提供了一种奈他地尔中间体的制备方法，具体而言，以苄醇衍生物为起始原料，经过苄醇基保护、羧基保护、Henry反应、脱水成烯、烯键还原、硝基还原、氨基保护、水解得到所需的中间体。本发明原料价廉易得，反应条件温和，反应可控性高，具有良好的工业化应用前景。

USPTO Abstract

本发明提供了一种奈他地尔中间体的制备方法，具体而言，以苄醇衍生物为起始原料，经过苄醇基保护、羧基保护、Henry反应、脱水成烯、烯键还原、硝基还原、氨基保护、水解得到所需的中间体。本发明原料价廉易得，反应条件温和，反应可控性高，具有良好的工业化应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN106939012B
Jurisdiction
CN
Classification
—
Expires
2019-11-08
Drug substance claim
No
Drug product claim
No
Assignee
Anhui ailide Pharmaceutical Co.,Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.